Viewing Study NCT05892068


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-02-04 @ 9:55 AM
Study NCT ID: NCT05892068
Status: RECRUITING
Last Update Posted: 2025-07-25
First Post: 2023-05-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tucatinib View
None HER2+ View
None Surgery View
None 22-168 View